SEC Form 4 · accession 0001209191-15-040840

HYPERION THERAPEUTICS INC · HPTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

May 7, 2015

Accepted (ET)

May 8, 2015 · 9:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001386858

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	May 4, 2015	G	4,348	$0.00	D	7,507	D
Common Stock^F1	May 4, 2015	G	1,087	$0.00	D	6,420	D
Common Stock^F1	May 4, 2015	G	1,087	$0.00	D	5,333	D
Common Stock^F1	May 4, 2015	G	327	$0.00	D	5,006	D
Common Stock^F2	May 7, 2015	U	5,006	$46.00	D	0	D
Common Stock^F3	May 7, 2015	D	2,617	$46.00	D	0	D
Common Stock^F2,F4	May 7, 2015	U	1,939,474	$46.00	D	0	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right to Buy)^F5	$7.31	May 7, 2015	D	4,105	D	—	Apr 15, 2022	Common Stock	4,105	D
Stock Option (Right to Buy)^F5	$24.46	May 7, 2015	D	9,800	D	—	Apr 14, 2023	Common Stock	9,800	D
Stock Option (Right to Buy)^F5	$26.97	May 7, 2015	D	4,869	D	—	May 26, 2024	Common Stock	4,869	D

F1Shares transferred as a gift.
F2Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
F3Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
F4The shares are owned directly by Sofinnova Venture Partners VII, L.P. ("SV VII"). Sofinnova Management VII, L.L.C. ("SV VII LLC"), the general partner of SV VII, and James Healy, a director of the Issuer, Michael Powell, and Eric Buatois, the managing members of SV VII LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV VII. Such persons and entities disclaim beneficial ownership over the shares owned by SV VII except to the extent of any pecuniary interest therein.
F5Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.